Katoh Nagaaki, Kubota Mayu, Shimojima Yasuhiro, Ishii Wataru, Matsuda Masayuki, Akamatsu Taiji, Ikeda Shu-ichi
Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, and Department of Endoscopy, Shinshu University Hospital, Matsumoto.
Intern Med. 2010;49(2):179-82. doi: 10.2169/internalmedicine.49.2491. Epub 2010 Jan 15.
We report a 20-year-old woman with Crohn's disease (CD) who developed anterior neck pain while being treated with the anti-tumor necrosis factor (TNF)-alpha monoclonal antibody, infliximab. She showed no symptoms suggestive of active CD except for tenderness along the left common carotid artery with marked increases in serum TNF-alpha and inflammatory reactions. Based on thickened walls of large vessels with enhancement effects on computed tomography, she was diagnosed as having associated Takayasu's arteritis (TA), which was successfully treated with corticosteroid. Even if CD is controlled by infliximab, other autoimmune disorders, such as TA, may develop as a complication.
我们报告了一名20岁患有克罗恩病(CD)的女性,她在接受抗肿瘤坏死因子(TNF)-α单克隆抗体英夫利昔单抗治疗时出现颈部前方疼痛。除了左颈总动脉压痛外,她没有提示活动性CD的症状,同时血清TNF-α和炎症反应显著增加。基于计算机断层扫描显示大血管壁增厚且有强化效应,她被诊断为合并高安动脉炎(TA),经皮质类固醇治疗成功。即使CD通过英夫利昔单抗得到控制,其他自身免疫性疾病,如TA,也可能作为并发症发生。